Derivatives: Adjustment in Active Biotech due to rights issue (02/18)


Extraordinary General Meeting (EGM) of Active Biotech AB (Active Biotech) held on March 19, 2018, approved a rights issue whereby shareholders are entitled to one (1) new share for every two (2) shares held. The subscription price is SEK 1.00 per share. The Ex-date is March 23, 2018. NASDAQ Derivatives Markets has carried out a re-calculation of options, forwards and futures in Active Biotech (ACTIB).

For further information please find attached file.

  


Attachments

02_Active_Biotech_rights_issue_2.pdf